What is an Anti-Endomysial IgA test?
The Anti-Endomysial IgA (EMA-IgA) test is a blood test that detects IgA antibodies against endomysial tissue.
These antibodies are strongly associated with celiac disease, an autoimmune condition in which eating gluten triggers an immune reaction that damages the lining of the small intestine.
EMA-IgA testing is considered a highly specific test for celiac disease and is commonly used together with tissue transglutaminase IgA (tTG-IgA) and measurement of total IgA.
What is the Anti-Endomysial IgA test used for?
The test may be used to:
Support the diagnosis of celiac disease
Evaluate patients with symptoms suggestive of celiac disease
Help investigate unexplained nutritional deficiencies or intestinal problems
Provide additional confirmation when a tTG-IgA result is positive or uncertain
Assess individuals at increased risk of celiac disease
EMA-IgA is generally more specific for celiac disease than tTG-IgA, although it can be more technically demanding and is often used as a confirmatory test.
Why do I need an Anti-Endomysial IgA test?
Your healthcare provider may request this test if you have symptoms or findings that could be associated with celiac disease, such as:
Chronic or recurrent diarrhea
Abdominal pain or bloating
Unexplained weight loss
Iron-deficiency anemia
Persistent fatigue
Nutritional deficiencies
Malabsorption
Osteoporosis or low bone density
Recurrent mouth ulcers
Unexplained elevation of certain liver enzymes
The test may also be recommended if you have a close family member with celiac disease or another condition associated with increased risk of celiac disease.
What happens during the test?
A small blood sample is collected from a vein in your arm.
The serum is tested for endomysial IgA antibodies, commonly using an indirect immunofluorescence (IIF) method.
Results are typically reported as:
Positive/Reactive
Negative/Non-reactive
Some laboratories may also report an antibody titer or additional interpretation according to the method used.
Will I need to do anything to prepare?
Usually, no fasting is required.
However, an important consideration is that you should generally continue eating gluten before celiac disease blood testing, unless your healthcare provider has specifically instructed you otherwise.
Following a gluten-free diet before testing can reduce antibody levels and may result in a false-negative result.
Your healthcare provider may also request total IgA because IgA deficiency can affect the reliability of IgA-based celiac antibody tests.
Do not start a gluten-free diet solely because you suspect celiac disease without discussing testing with your healthcare provider.
Are there any risks?
The test involves a routine blood collection. You may experience minor discomfort, bruising, or tenderness at the collection site.
Serious complications are very uncommon.
What do the results mean?
Positive result
A positive Anti-Endomysial IgA result means that IgA antibodies against endomysial tissue were detected.
A positive EMA-IgA result is strongly supportive of celiac disease, particularly when the patient is consuming gluten and the clinical findings are compatible.
Further evaluation may include:
Tissue transglutaminase IgA (tTG-IgA)
Total IgA
Deamidated gliadin peptide (DGP) antibodies when appropriate
Additional clinical evaluation
Small-intestinal biopsy in adults or other situations where confirmation is clinically indicated
A positive result should be interpreted by a healthcare professional together with the patient's symptoms and other laboratory findings.
Negative result
A negative Anti-Endomysial IgA result means that EMA-IgA antibodies were not detected.
This makes celiac disease less likely, particularly when the patient is consuming sufficient gluten and has a normal total IgA level.
However, a negative result does not completely exclude celiac disease.
False-negative or negative results may occur in:
Patients with IgA deficiency
Patients who have already reduced or eliminated gluten from their diet
Some patients with early or mild disease
Certain pediatric or clinically atypical cases
If clinical suspicion remains high, additional testing such as tTG-IgA, total IgA, or IgG-based testing may be appropriate.
Important note about the results
Anti-Endomysial IgA is a highly specific serological marker for celiac disease, but it should not be interpreted as a stand-alone diagnostic test.
For reliable serological testing, the patient should generally be consuming gluten at the time of testing. Testing after starting a gluten-free diet may produce negative results even when celiac disease is present.
Total IgA should be considered when interpreting IgA-based celiac serology, because selective IgA deficiency can cause falsely negative IgA antibody results.
EMA-IgA is commonly interpreted together with tTG-IgA, clinical findings, and, when indicated, small-intestinal histology. The exact testing strategy may differ according to the patient's age, clinical situation, and applicable diagnostic guidelines.
Results should always be interpreted according to the specific assay method, laboratory reference criteria, and the patient's clinical context.
Prefer to talk to someone first? Contact us to book.
